Freebird Partners LP ownership in Eterna Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA)
2025-01-28 - Freebird Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.14M shares of Eterna Therapeutics Inc. Common Stock, par value $0.005 per share (ERNA).
This represents 9.99% percent ownership of the company.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.